Advertisement
Original communication| Volume 92, ISSUE 1, P101-108, July 1982

Download started.

Ok

Myocardial protection with prostacyclin after lethal endotoxemia

  • Takayoshi Utsunomiya
    Affiliations
    From the Department of Surgery, Brigham and Women's Hospital Experimental Pathology Laboratory, Eye Research Institute Boston, Mass., USA

    From the Harvard University School of Medicine, USA

    From the Biological Science Center, Boston University, Boston, Mass., USA
    Search for articles by this author
  • Michael M. Krausz
    Affiliations
    From the Department of Surgery, Brigham and Women's Hospital Experimental Pathology Laboratory, Eye Research Institute Boston, Mass., USA

    From the Harvard University School of Medicine, USA

    From the Biological Science Center, Boston University, Boston, Mass., USA
    Search for articles by this author
  • Makio Kobayashi
    Affiliations
    From the Department of Surgery, Brigham and Women's Hospital Experimental Pathology Laboratory, Eye Research Institute Boston, Mass., USA

    From the Harvard University School of Medicine, USA

    From the Biological Science Center, Boston University, Boston, Mass., USA
    Search for articles by this author
  • David Shepro
    Affiliations
    From the Department of Surgery, Brigham and Women's Hospital Experimental Pathology Laboratory, Eye Research Institute Boston, Mass., USA

    From the Harvard University School of Medicine, USA

    From the Biological Science Center, Boston University, Boston, Mass., USA
    Search for articles by this author
  • Herbert B. Hechtman
    Correspondence
    Reprint requests: Herbert B. Hechtman, M.D., Brigham and Women's Hospital, 75 Francis St., Boston, MA 02115.
    Affiliations
    From the Department of Surgery, Brigham and Women's Hospital Experimental Pathology Laboratory, Eye Research Institute Boston, Mass., USA

    From the Harvard University School of Medicine, USA

    From the Biological Science Center, Boston University, Boston, Mass., USA
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      A previous study of endotoxemia in dogs demonstrated that exogenous prostacyclin (PGI2), normally a product of vascular endothelium, restored the cardiac index to normal and improved survival. To account for these results, a study was undertaken to test whether PGI2 would alter isolated rat or dog cardiac mitochondrial function following incubation with plasma from endotoxemic animals. A group of five animals served as anesthetized controls. A second group of seven mongrel dogs was given 1.75 mg Escherichia coli endotoxin/kg and was observed for 5 hours without treatment. Anesthesia did not alter cardiopulmonary function; however, 30 minutes after endotoxin administration, the cardiac index decreased from 148 ± 25 (Math Eq ± SD) to 111 ± 12 ml/kg · min (P < 0.05) and further decreased to 89 ± 20 ml/kg · min after 4 hours. Dog plasma obtained 2 to 5 hours after endotoxin infusion, incubated with rat or dog myocardial mitochondria, decreased succinate dehydrogenase (SDH) activity (P < 0.05) and depressed mitochondrial respiration in the presence of the substrate succinate and adenosine diphosphate (ADP) from 180 to 87 Natoms oxygen/mg protein · min (P < 0.05). There was no change in oxygen consumption when substrate alone was present, nor did plasma alter the amount of ADP phosphorylation as a function of oxygen consumption. A third group of seven animals, 30 minutes after administration of 7.75 mg endotoxin/kg, was treated with 100 ng/kg · min PGI2 for 3 hours. PGI2 infusion in this group prevented the decrease in cardiac index. Plasma obtained during and after PGI2 infusion did not decrease mitochondrial SDH activity, which remained higher than that in controls (P < 0.001); mitochondrial respiration was also not altered. A correlation was observed between cardiac index and SDH activity (r = 0.58, P < 0.001) and between cardiac index and mitochondrial respiration (r = 0.67, P < 0.001). In PGI2-treated dogs cardiac mitochondria were functionally and structurally normal in contrast to the depression and disruption produced by endotoxemia, as observed by enzymatic assay as well as electron microscopy. These results suggest that endotoxemia depresses cardiac mitochondrial respiration, an event related to the decrease in cardiac index. In contrast, cardiac function and mitochondrial respiration are maintained with PGI2 treatment.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Gilbert R
        Mechanisms of the hemodynamic effects of endotoxin.
        Physiol Rev. 1960; 40: 245-279
        • Grindlinger GA
        • Manny J
        • Justice R
        • Dunham B
        • Shepro D
        • Hechtman HB
        Presence of negative inotropic agents in canine plasma during positive end-expiratory pressure.
        Circ Res. 1979; 45: 460-467
        • Justice RE
        • Krausz MM
        • Valeri CR
        • Shepro D
        • Hechtman HB
        A miniaturized chamber for the measure of oxygen consumption.
        J Appl Physiol. 1982; 52: 488-490
        • Kadowitz PJ
        • Chapnick BM
        • Feigen LP
        • Hyman AL
        • Nelson PK
        • Spannhake EW
        Pulmonary and systemic vasodilator effects of the newly discovered prostaglandin, PGI2.
        J Appl Physiol. 1978; 45: 408-413
        • Katz AM
        Physiology of the heart.
        Raven Press, New York1977
        • King TE
        Reconstitution ot respiratory chain enzyme systems. XI. Use of artificial electron acceptors in the assay of succinate dehydrogenating enzymes.
        J Biol Chem. 1963; 238: 4032-4036
        • Krausz MM
        • Utsunomiya T
        • Feuerstein G
        • Wolfe JHN
        • Shepro D
        • Hechtman HB
        Prostacyclin (PGI2) reversal of lethal endotoxemia in dogs.
        J Clin Invest. 1981; 67: 1118-1125
        • Lefer AM
        • Sollott SL
        • Galvin MJ
        Beneficial actions of prostacyclin in traumatic shock.
        Prostaglandins. 1970; 17: 761-767
        • Lefer AM
        • Tabas J
        • Smith EF
        Salutary effects of prostacyclin in endotoxin shock.
        Pharmacology. 1980; 21: 206-212
        • Lowry OH
        Protein measurement with the folin phenol reagent.
        J Biol Chem. 1951; 193: 265-275
        • McGiveney A
        • Bradley SG
        Action of bacterial endotoxin and lipid A on mitochondrial enzyme activities of cells in cultures and subcellular fraction.
        Infect Immunol. 1979; 25: 664-671
        • McGiveney A
        • Bradley SG
        Effects of bacterial endotoxin on lysosomal and mitochondrial enzyme activities of established cell cultures.
        J Reticuloendothel Soc. 1979; 26: 307-316
        • Rai DK
        • Gupta LP
        • Singh RH
        • Udupa KN
        A study of microcirculation in endotoxin shock.
        Surg Gynecol Obstet. 1974; 139: 11-16
        • Siegel JH
        • Corra FB
        • Coleman B
        • Giovannini I
        • Shetye M
        • Border JR
        • McMenamy RJ
        Physiologic and metabolic correlations in human sepsis.
        Surgery. 1979; 86: 163-193
        • Sordahl LA
        • Johnson C
        • Blalock ZR
        • Schwanz A
        The mitochondria.
        Methods Pharmacol. 1971; 1: 247-286
        • Utsunomiya T
        Studies on pulmonary complications due to cardiopulmonary bypass. II. Pulmonary changes after cardiopulmonary bypass in dogs.
        Kumamoto Med J. 1976; 29: 161-171